Andrade A, da Motta Girardi J, da Silva E, Barbosa J, Pereira D
Syst Rev. 2024; 13(1):291.
PMID: 39605094
PMC: 11600673.
DOI: 10.1186/s13643-024-02715-w.
Edgar J, Bournazos S
Immunol Rev. 2024; 328(1):221-242.
PMID: 39268652
PMC: 11659939.
DOI: 10.1111/imr.13393.
Beyze A, Larroque C, le Quintrec M
Nat Rev Nephrol. 2024; 20(10):672-689.
PMID: 38961307
DOI: 10.1038/s41581-024-00850-0.
Bauer-Smith H, Sudol A, Beers S, Crispin M
Biochim Biophys Acta Gen Subj. 2023; 1867(11):130448.
PMID: 37652365
PMC: 11032748.
DOI: 10.1016/j.bbagen.2023.130448.
Cao D, Deng C, Wang G, Mei X, Xie J, Liu Y
Drugs R D. 2023; 23(3):267-288.
PMID: 37479945
PMC: 10439073.
DOI: 10.1007/s40268-023-00432-8.
Glycosylation shapes the efficacy and safety of diverse protein, gene and cell therapies.
Rocamora F, Peralta A, Shin S, Sorrentino J, Wu M, Toth E
Biotechnol Adv. 2023; 67:108206.
PMID: 37354999
PMC: 11168894.
DOI: 10.1016/j.biotechadv.2023.108206.
Production of recombinant human IgG1 Fc with beneficial N-glycosylation pattern for anti-inflammatory activity using genome-edited chickens.
Park J, Choi H, Jung K, Lee K, Shim J, Park K
Commun Biol. 2023; 6(1):589.
PMID: 37264071
PMC: 10235082.
DOI: 10.1038/s42003-023-04937-5.
Integrated summary of immunogenicity of polatuzumab vedotin in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma.
Dere R, Beardsley R, Lu D, Lu T, Ku G, Man G
Front Immunol. 2023; 14:1119510.
PMID: 37063860
PMC: 10090561.
DOI: 10.3389/fimmu.2023.1119510.
Risk-Based Control Strategies of Recombinant Monoclonal Antibody Charge Variants.
Beck A, Nowak C, Meshulam D, Reynolds K, Chen D, Pacardo D
Antibodies (Basel). 2022; 11(4).
PMID: 36412839
PMC: 9703962.
DOI: 10.3390/antib11040073.
Challenges and Strategies for a Thorough Characterization of Antibody Acidic Charge Variants.
Liu Y, Cadang L, Bol K, Pan X, Tschudi K, Jazayri M
Bioengineering (Basel). 2022; 9(11).
PMID: 36354552
PMC: 9687119.
DOI: 10.3390/bioengineering9110641.
Process- and Product-Related Foulants in Virus Filtration.
Isu S, Qian X, Zydney A, Wickramasinghe S
Bioengineering (Basel). 2022; 9(4).
PMID: 35447715
PMC: 9030149.
DOI: 10.3390/bioengineering9040155.
Mannose-binding analysis and biological application of pradimicins.
Nakagawa Y, Ito Y
Proc Jpn Acad Ser B Phys Biol Sci. 2022; 98(1):15-29.
PMID: 35013028
PMC: 8795531.
DOI: 10.2183/pjab.98.002.
Optimization of therapeutic antibodies.
Wang B, Gallolu Kankanamalage S, Dong J, Liu Y
Antib Ther. 2021; 4(1):45-54.
PMID: 33928235
PMC: 7944496.
DOI: 10.1093/abt/tbab003.
Engineering Anti-Tumor Monoclonal Antibodies and Fc Receptors to Enhance ADCC by Human NK Cells.
Dixon K, Wu J, Walcheck B
Cancers (Basel). 2021; 13(2).
PMID: 33467027
PMC: 7829765.
DOI: 10.3390/cancers13020312.
MS-Based Allotype-Specific Analysis of Polyclonal IgG-Fc -Glycosylation.
Senard T, Gargano A, Falck D, de Taeye S, Rispens T, Vidarsson G
Front Immunol. 2020; 11:2049.
PMID: 32973813
PMC: 7472933.
DOI: 10.3389/fimmu.2020.02049.
Principles of -Linked Glycosylation Variations of IgG-Based Therapeutics: Pharmacokinetic and Functional Considerations.
Boune S, Hu P, Epstein A, Khawli L
Antibodies (Basel). 2020; 9(2).
PMID: 32532067
PMC: 7345016.
DOI: 10.3390/antib9020022.
Interaction analysis of glycoengineered antibodies with CD16a: a native mass spectrometry approach.
Hajduk J, Brunner C, Malik S, Bangerter J, Schneider G, Thomann M
MAbs. 2020; 12(1):1736975.
PMID: 32167012
PMC: 7153833.
DOI: 10.1080/19420862.2020.1736975.
Factor VIII Fc Fusion Protein but not FVIII Drives Human Monocyte-Derived Dendritic Cell Activation via FcγRIIa.
Kannicht C, Danssmann I, Weilandt C, Derkow K, Kohla G, Geyer H
Hemasphere. 2020; 4(1):e330.
PMID: 32072146
PMC: 7000470.
DOI: 10.1097/HS9.0000000000000330.
On enzymatic remodeling of IgG glycosylation; unique tools with broad applications.
Sjogren J, Lood R, Nageli A
Glycobiology. 2019; 30(4):254-267.
PMID: 31616919
PMC: 7109354.
DOI: 10.1093/glycob/cwz085.
In Silico Methods in Antibody Design.
Zhao J, Nussinov R, Wu W, Ma B
Antibodies (Basel). 2019; 7(3).
PMID: 31544874
PMC: 6640671.
DOI: 10.3390/antib7030022.